[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-357245-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-357245-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hormone-secretion-predicts-poor-prognosis-in-lung-neuroendocrine-neoplasms-research-article","Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms - Research article","","Ectopic hormone secretion from neuroendocrine neoplasms in the lung (lung-NENs) is rare and insufficiently studied. The study tests the hypothesis that ectopic hormone production and secretion mark worse outcomes. A retrospective cohort of 167 lung-NEN patients was analyzed for clinical and biochemical data and tumor serotonin and calcitonin expression. Increased hormone levels were common, with 5-HIAA predominating, and calcitonin correlating with calcitonin expression. Diffuse calcitonin staining and multiple hormone secretion were linked to shorter overall survival. Routine hormone testing is recommended at baseline and during progression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hormone-secretion-predicts-poor-prognosis-in-lung-neuroendocrine-neoplasms-research-article/357245/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hormone-secretion-predicts-poor-prognosis-in-lung-neuroendocrine-neoplasms-research-article/357245.png","ImageObject",300,407,{"name":42,"@type":43},"4398046744996","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What motivated the study of hormone secretion in lung neuroendocrine neoplasms?","Question",{"text":63,"@type":64},"Ectopic hormone secretion from lung-NENs is rare but emerging evidence suggests hormone-secreting tumors have a worse prognosis. The study hypothesized that ectopic hormone production and secretion act as a negative prognostic marker.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were hormones and tumor expression assessed in the cohort?",{"text":68,"@type":64},"A retrospective cohort of 167 lung-NEN patients (excluding small cell lung cancer) was evaluated using clinical and biochemical data. Tumor tissue was assessed for serotonin and calcitonin expression.",{"name":70,"@type":61,"acceptedAnswer":71},"Which hormone-related findings were linked to poorer overall survival?",{"text":72,"@type":64},"Multiple hormone secretion worsened survival compared with single or non-secreting tumors. Additionally, diffuse calcitonin staining in tumor tissue was associated with shorter overall survival, and high calcitonin levels strongly correlated with calcitonin expression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},357245,1790177079,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":11,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":133,"file_id":134,"file_url":135,"file_type":136,"file_size":137,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":138,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":139,"faqs":140,"seo_title":141,"seo_description":12,"update_tm":142,"read_time":143,"preview_page_count":33,"preview_urls":144},4398046744996,"Endocrine-Related Cancer (2026) 33 e260142  \n[https://doi.org/10.1530/ERC-26-0142](https://doi.org/10.1530/ERC-26-0142)  \nRESEARCH  \nReceived 17 March 2026 Accepted 1 June 2026 Available online 2 June 2026  \nVersion of Record published 18 June 2026  \n\n| Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms\u003Cbr>Ieva Lase􀀁1, Eir Lfgren1, Agnes Hegedus2, Malin Grnberg1, Staffan Welin1 and Eva Tiensuu Janson1\u003Cbr>1Department of Medical Sciences, Endocrine Oncology Unit, Uppsala University, Uppsala, Sweden\u003Cbr>2Department of Immunology, Genetics and Pathology, Uppsala University and Uppsala University Hospital, Uppsala, Sweden\u003Cbr>Correspondence should be addressed to I Lase: ieva.lase@medsci.uu.se |\n| --- |\n| Abstract\u003Cbr>Ectopic hormone secretion from neuroendocrine neoplasms in the lung (lung-NENs) is rare and poorly explored. Emerging evidence indicates that hormone-secreting NENs carry a worse prognosis. We hypothesised that ectopic hormone production and secretion in lung-NENs is a negative prognostic marker. A retrospective cohort of 167 patients with lung-NENs (121 females, median age: 68 (min–max: 15–85) years), excluding small cell lung cancer, was analysed for clinical and biochemical data and outcome. Tumour tissue was evaluated for serotonin and calcitonin expression. Among 127 patients with hormone measurements, 52 had increased levels, with 5-hydroxyindoleacetic acid (5-HIAA) predominating (n = 38), followed by calcitonin (n = 20). There was no correlation between serotonin expression in tumour tissue and elevated levels of 5-HIAA, while high calcitonin levels were strongly correlated with calcitonin expression in tumour samples (OR: 21.86, P = 0.002) . Furthermore, diffuse calcitonin staining was associated with a shorter overall survival (OS) (P = 0.036) . Hormone-secreting tumours had a signiﬁcantly shorter OS than non-secreting tumours (62 vs 124 months, P = 0.024), and multiple hormone secretion further worsened survival (33 vs 69 vs 124 months, P = 0.002) . In multivariate analysis, multiple hormone secretion remained an independent negative prognostic factor (P = 0.042) . In conclusion, hormone secretion in lung-NENs is associated with a shorter OS, particularly in patients with multiple hormone secretion. Diffuse calcitonin expression in tumour tissue is an additional negative prognostic marker. We recommend routine hormone testing at baseline and at disease progression in metastatic lung-NEN patients and suggest a more intensiﬁed therapeutic strategy in cases with detectable hormone secretion.\u003Cbr>Keywords: neuroendocrine; lungs; serotonin; multiple; prognosis |\n\nIntroduction  \nAlthough well-differentiated neuroendocrine neoplasms in the lung (lung-NENs) are still considered rare tumours, their incidence is increasing (1) . It is well known that lung-NENs can produce various ectopic hormones, such as ACTH, serotonin and calcitonin; however, the prevalence and prognostic signiﬁcance of ectopic hormone production remain poorly understood.  \nLung-NENs are classiﬁed by cell morphology, mitotic count/2 mm2 (MC) and necrosis in the primary tumours as follows: typical carcinoid (TC) with MC \u003C 2 and no necrosis; atypical carcinoid (AC) with MC 2–10 and/or  \nnecrosis; large cell neuroendocrine carcinoma (LCNEC) with MC > 10 and large cell cytomorphology; and small cell lung cancer (SCLC) with MC > 10 and small cell cytomorphology (2) . Since the classiﬁcation of lung-NENs is an important prognostic factor and guides therapeutic decisions also in metastatic disease, accurate histopathological subtyping is clinically relevant. However, in small biopsy specimens, assessment of MC and identiﬁcation of necrosis can be challenging (3) . The recent WHO classiﬁcation (2) introduced the term‘carcinoid tumour/metastatic carcinoid not otherwise  \nPublished by Bioscientiﬁca Ltd.  \n[https://erc.bioscienti](https://erc.bioscienti)ﬁ[ca.com](ca.com)  \n© 2026 the author(s)  \nThis work is licensed under a Creative Commo","cbCaipetP5UqnSgh","https://ap.wps.com/l/cbCaipetP5UqnSgh","pdf",688458,"English","# Abstract\n# Introduction\n## Classification and clinical relevance of lung neuroendocrine neoplasms\n## Ectopic hormone secretion and endocrine paraneoplastic syndromes\n# Methods\n## Patient cohort and biochemical assessment\n## Tumor expression evaluation\n# Results\n## Hormone measurements and associations\n## Survival analysis and prognostic impact\n# Conclusion\n## Clinical recommendations for hormone testing","[{\"question\":\"What motivated the study of hormone secretion in lung neuroendocrine neoplasms?\",\"answer\":\"Ectopic hormone secretion from lung-NENs is rare but emerging evidence suggests hormone-secreting tumors have a worse prognosis. The study hypothesized that ectopic hormone production and secretion act as a negative prognostic marker.\"},{\"question\":\"How were hormones and tumor expression assessed in the cohort?\",\"answer\":\"A retrospective cohort of 167 lung-NEN patients (excluding small cell lung cancer) was evaluated using clinical and biochemical data. Tumor tissue was assessed for serotonin and calcitonin expression.\"},{\"question\":\"Which hormone-related findings were linked to poorer overall survival?\",\"answer\":\"Multiple hormone secretion worsened survival compared with single or non-secreting tumors. Additionally, diffuse calcitonin staining in tumor tissue was associated with shorter overall survival, and high calcitonin levels strongly correlated with calcitonin expression.\"}]","Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms - Research article | PDF",1790129459,25,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1680518323ef76c0109b4c06a591416.webp",983,1269,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/000fc7e82754b203638a17efef03aaf7.webp",982,1268,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e4e1f6d1f1e79b9af621675cb819959.webp",981,1266,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da6d1eac333844ab3db337fc18e0644e.webp",980,1265]